Clinical Trial Update: Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults [NA]

View source ↗

Summary

Clinical trial evaluating paromomycin versus metronidazole for symptomatic Dientamoeba fragilis infection in adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dientamoeba Fragilis Infection

Drugs mentioned

• METRONIDAZOLE (Metronidazole)
• Paromomycin (paromomycin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Dientamoeba Fragilis Infection | NA | Status: RECRUITING